^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

CENPF (Centromere Protein F)

i
Other names: CENPF, Centromere Protein F, Mitosin , Hcp-1, Centromere Protein F, 350/400kDa, Kinetochore Protein CENPF, AH Antigen, Centromere Protein F, 350/400kDa (Mitosin), Cell-Cycle-Dependent 350K Nuclear Protein, CENP-F Kinetochore Protein, PRO1779, CILD31, STROMS, CENP-F, CENF
Associations
Trials
1m
Integrated Network Analysis Reveals a Directly Regulatory Network of FOXM1 Associated With the Cell Cycle in Lung Adenocarcinoma. (PubMed, Bioinform Biol Insights)
The predicted regulatory network of FOXM1 shows significant discrepancies with experimental validation data. Therefore, FOXM1's regulatory role in the cell cycle requires further experimental verification.
Journal
|
TOP2A (DNA topoisomerase 2-alpha) • FOXM1 (Forkhead Box M1) • MELK (Maternal Embryonic Leucine Zipper Kinase) • CENPF (Centromere Protein F) • KIF20A (Kinesin Family Member 20A)
2ms
MYBL2 regulates the expression of CENPF in lung adenocarcinoma and promotes tumor development and metastasis through AKT pathway activation. (PubMed, Eur J Med Res)
The expression of MYBL2 and CENPF in lung adenocarcinoma increases with LUAD progression. MYBL2 regulates the expression of CENPF in LUAD, and the elevated CENPF promotes the proliferation and migration of LUAD cells. Both MYBL2 and CENPF regulate the proliferation and migration of LUAD through AKT pathway activation.
Journal
|
MYBL2 (MYB Proto-Oncogene Like 2) • CENPF (Centromere Protein F)
|
ipatasertib (RG7440)
4ms
CENP-F promotes HCC cell proliferation mediated by super enhancer reader BRD4. (PubMed, Discov Oncol)
In addition, downregulation of BRD4 using siRNA and JQ1 led to decreases in the protein levels of BRD4 and c-Myc...These findings suggested that CENP-F regulated the proliferation of HCC cells through the CENP-F-CDK1/CDK2-BRD4 axis. In conclusion, our study revealed a new mechanism by which CENP-F promotes HCC cell proliferation by the SE reader BRD4, suggesting that SEs play an essential role in mediating HCC treatment.
Journal
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • BRD4 (Bromodomain Containing 4) • CDK7 (Cyclin Dependent Kinase 7) • CDK1 (Cyclin-dependent kinase 1) • CENPF (Centromere Protein F)
|
JQ-1
5ms
WTAP Promotes Malignant Progression and Immune Escape of Glioblastoma by Regulating N6-methyladenosine Modification of CENPF. (PubMed, J Biochem Mol Toxicol)
Together, WTAP promotes cell malignant progression and immune escape in GBM through regulating m6A modification of CENPF. These findings may provide a novel theoretical basis for the treatment of GBM.
Journal
|
CD8 (cluster of differentiation 8) • WT1 (WT1 Transcription Factor) • CASP3 (Caspase 3) • CENPF (Centromere Protein F) • WTAP (WT1 Associated Protein)
6ms
Prognostic Value and Immune Characterization of Genes Associated with Childhood Acute Leukemia applying Single-Cell RNA Sequencing. (PubMed, Endocr Metab Immune Disord Drug Targets)
This study revealed the critical role of B cells in cALL, and the prognostic model showed a high prediction accuracy, providing a potential target for individualized treatment of cALL.
Journal
|
PSMA2 (Proteasome 20S Subunit Alpha 2) • CENPF (Centromere Protein F) • IGLL1 (Immunoglobulin Lambda Like Polypeptide 1)
7ms
CENPF overexpression in bladder cancer cells enhances proliferation, migration, invasion, and apoptosis. (PubMed, Sci Rep)
Taken together, these results demonstrated that CENPF may serve as a potential biomarker of tumor occurrence, progression, and even prognosis for bladder cancer. However, further research is needed to be further clarified the pathway mechanisms of CENPF in bladder cancer.
Journal
|
CENPF (Centromere Protein F)
8ms
Nano-delivery of miRNA inhibiting CENPF combined with cisplatin for bladder cancer treatment. (PubMed, RSC Adv)
The PDA-based system combines the DNA-damaging effects of cisplatin with the gene-silencing properties of miR-205-5p, resulting in synergistic antitumor activity. This multimodal strategy enhances therapeutic precision and efficacy, providing a promising solution for BCa treatment with significant clinical potential.
Journal
|
CENPF (Centromere Protein F) • MIR205 (MicroRNA 205)
10ms
PSMD14/E2F1 Axis-Mediated CENPF Promotes the Metastasis of Triple-Negative Breast Cancer Through Inhibiting Ferroptosis. (PubMed, Cancer Sci)
The PSMD14/E2F1 axis-mediated CENPF could promote the metastasis of TNBC by inhibiting arachidonic acid metabolism-induced ferroptosis. This research might bring novel insights into discovering methods for alleviating tumor metastasis in TNBC.
Journal
|
CENPF (Centromere Protein F) • E2F1 (E2F transcription factor 1) • PSMD14 (Proteasome 26S Subunit, Non-ATPase 14)
10ms
Centromere Protein F Is a Potential Prognostic Biomarker and Target for Cutaneous Melanoma. (PubMed, Biomedicines)
Its upregulation drives tumor progression through cell cycle dysregulation and immune evasion, while targeting the E2F3-CENPF axis may offer a novel strategy for melanoma treatment. These findings provide critical insights into melanoma pathogenesis and potential clinical applications.
Journal
|
CENPF (Centromere Protein F) • E2F3 (E2F transcription factor 3)
11ms
CENPF as a Potential Biomarker Associated with the Immune Microenvironment of Renal Cancer. (PubMed, Technol Cancer Res Treat)
Prognostic analysis indicated that high follicular helper T-cell expression predicted poorer survival, while high plasma cell expression correlated with better outcomes.ConclusionCENPF plays a critical role in tumor progression and the modulation of the tumor immune microenvironment in KIRC. These findings suggest that CENPF could serve as a valuable prognostic biomarker and potential target for therapeutic intervention in renal cancer.
Retrospective data • Journal
|
CENPF (Centromere Protein F)
12ms
CENPF interaction with PLA2G4A promotes glioma growth by modulating mTORC1 and NF-κB pathways. (PubMed, Cancer Cell Int)
This study found that CENPF plays a key role in promoting tumorigenesis through its interaction with PLA2G4A. This study provides a theoretical foundation for advancing multi-targeted therapies in glioma and for developing strategies to overcome tumor drug resistance.
Journal
|
CENPF (Centromere Protein F)
12ms
CENPF as a prognostic marker of glioma: unraveling the molecular mechanisms. (PubMed, J Cancer Res Clin Oncol)
CENPF exhibits elevated expression levels in glioma, potentially inhibiting cell apoptosis via the p53 signaling pathway, consequently contributing to the onset and progression of glioma.
Journal
|
TOP2A (DNA topoisomerase 2-alpha) • NUSAP1 (Nucleolar and Spindle Associated Protein 1) • CDC20 (Cell Division Cycle 20) • CDK1 (Cyclin-dependent kinase 1) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • CENPF (Centromere Protein F) • KIF20A (Kinesin Family Member 20A) • KIF23 (Kinesin Family Member 23) • KIF2C (Kinesin Family Member 2C)